Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Neoplasms of the CNS

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 35 articles: HTML format

Single Articles

September 2025
1. KRISHNAN S, Lee S, Amoozgar Z, Subudhi S, et al
   Wnt inhibition alleviates resistance to anti-PD1 therapy and improves antitumor immunity in glioblastoma.
   Proc Natl Acad Sci U S A. 2025;122:e2414941122.
   PubMed     Abstract available
   
   
   
2. KEAHI DL, Sanders MA, Paul MR, Webster ALH, et al
   G-quadruplexes as a source of vulnerability in BRCA2-deficient granule cell progenitors and medulloblastoma.
   Proc Natl Acad Sci U S A. 2025;122:e2503872122.
   PubMed     Abstract available
   
   
   August 2025
3. KHAN F, Liu Y, Whitfield D, Pang L, et al
   Macrophage TBK1 signaling drives the development and outgrowth of breast cancer brain metastasis.
   Proc Natl Acad Sci U S A. 2025;122:e2420793122.
   PubMed     Abstract available
   
   
   July 2025
4. ZHOU L, Song Q, Zhang X, Cao M, et al
   In vivo generation of CAR macrophages via the enucleated mesenchymal stem cell delivery system for glioblastoma therapy.
   Proc Natl Acad Sci U S A. 2025;122:e2426724122.
   PubMed     Abstract available
   
   
   
5. ZHU Z, Wang H, Li T, Huang TM, et al
   OMT and tensor SVD-based deep learning model for segmentation and predicting genetic markers of glioma: A multicenter study.
   Proc Natl Acad Sci U S A. 2025;122:e2500004122.
   PubMed     Abstract available
   
   
   June 2025
6. 
   Correction for Feng et al., Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis.
   Proc Natl Acad Sci U S A. 2025;122:e2511499122.
   PubMed    
   
   
   May 2025
7. 
   Correction to Supporting Information for Jensen et al., Bcl2L13 is a ceramide synthase inhibitor in glioblastoma.
   Proc Natl Acad Sci U S A. 2025;122:e2507673122.
   PubMed    
   
   
   
8. ZHANG L, Yang J, Zhou Z, Ren Y, et al
   A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity.
   Proc Natl Acad Sci U S A. 2025;122:e2427073122.
   PubMed     Abstract available
   
   
   April 2025
9. 
   Correction for He et al., Radiation-induced cellular plasticity primes glioblastoma for forskolin-mediated differentiation.
   Proc Natl Acad Sci U S A. 2025;122:e2506044122.
   PubMed    
   
   
   March 2025
10. 
    Correction for Xu et al., BCL6 promotes glioma and serves as a therapeutic target.
    Proc Natl Acad Sci U S A. 2025;122:e2504152122.
    PubMed    
    
    
    
11. DI CARO V, Cesari P, Sala F, Cattaneo L, et al
    The neural bases of the reach-grasp movement in humans: Quantitative evidence from brain lesions.
    Proc Natl Acad Sci U S A. 2025;122:e2419801122.
    PubMed     Abstract available
    
    
    
12. HE L, Azizad D, Bhat K, Ioannidis A, et al
    Radiation-induced cellular plasticity primes glioblastoma for forskolin-mediated differentiation.
    Proc Natl Acad Sci U S A. 2025;122:e2415557122.
    PubMed     Abstract available
    
    
    February 2025
13. LI J, Shih LK, Markwell SM, Olson CL, et al
    A clinically relevant model and method to study necrosis as a driving force in glioma restructuring and progression.
    Proc Natl Acad Sci U S A. 2025;122:e2416024122.
    PubMed     Abstract available
    
    
    January 2025
14. REN J, Amoozgar Z, Uccello TP, Lei PJ, et al
    Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma.
    Proc Natl Acad Sci U S A. 2025;122:e2319474122.
    PubMed     Abstract available
    
    
    
15. FURTH N, Cohen N, Spitzer A, Salame TM, et al
    Oncogenic IDH1(mut) drives robust loss of histone acetylation and increases chromatin heterogeneity.
    Proc Natl Acad Sci U S A. 2025;122:e2403862122.
    PubMed     Abstract available
    
    
    December 2024
16. HSIEH AL, Ganesh S, Kula T, Irshad M, et al
    Widespread neuroanatomical integration and distinct electrophysiological properties of glioma-innervating neurons.
    Proc Natl Acad Sci U S A. 2024;121:e2417420121.
    PubMed     Abstract available
    
    
    August 2024
17. 
    Correction for Kudruk et al., Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy.
    Proc Natl Acad Sci U S A. 2024;121:e2413733121.
    PubMed    
    
    
    June 2024
18. HUA W, Zhang W, Brown H, Wu J, et al
    Rapid detection of IDH mutations in gliomas by intraoperative mass spectrometry.
    Proc Natl Acad Sci U S A. 2024;121:e2318843121.
    PubMed     Abstract available
    
    
    May 2024
19. ASHOKAN A, Sarkar S, Kamran MZ, Surnar B, et al
    Simultaneous targeting of peripheral and brain tumors with a therapeutic nanoparticle to disrupt metabolic adaptability at both sites.
    Proc Natl Acad Sci U S A. 2024;121:e2318119121.
    PubMed     Abstract available
    
    
    
20. GOYETTE MA, Stevens LE, DePinho CR, Seehawer M, et al
    Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies.
    Proc Natl Acad Sci U S A. 2024;121:e2322688121.
    PubMed     Abstract available
    
    
    April 2024
21. WU R, Sun C, Chen X, Yang R, et al
    NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion.
    Proc Natl Acad Sci U S A. 2024;121:e2321611121.
    PubMed     Abstract available
    
    
    March 2024
22. SAITO Y, Yang Y, Saito M, Park CY, et al
    NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells.
    Proc Natl Acad Sci U S A. 2024;121:e2314695121.
    PubMed     Abstract available
    
    
    February 2024
23. WANG R, Lei H, Wang H, Qi L, et al
    Dysregulated inter-mitochondrial crosstalk in glioblastoma cells revealed by in situ cryo-electron tomography.
    Proc Natl Acad Sci U S A. 2024;121:e2311160121.
    PubMed     Abstract available
    
    
    
24. NOCH EK, Palma L, Yim I, Bullen N, et al
    Cysteine induces mitochondrial reductive stress in glioblastoma through hydrogen peroxide production.
    Proc Natl Acad Sci U S A. 2024;121:e2317343121.
    PubMed     Abstract available
    
    
    
25. KUDRUK S, Forsyth CM, Dion MZ, Hedlund Orbeck JK, et al
    Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy.
    Proc Natl Acad Sci U S A. 2024;121:e2306973121.
    PubMed     Abstract available
    
    
    December 2023
26. WEN J, Nasrallah IM, Abdulkadir A, Satterthwaite TD, et al
    Genomic loci influence patterns of structural covariance in the human brain.
    Proc Natl Acad Sci U S A. 2023;120:e2300842120.
    PubMed     Abstract available
    
    
    September 2023
27. PANT A, Lim M
    Overcoming EGFR inhibitor resistance in Glioblastoma by targeting co-amplified genes.
    Proc Natl Acad Sci U S A. 2023;120:e2312277120.
    PubMed    
    
    
    August 2023
28. ROY A, Sakthikumar S, Kozyrev SV, Nordin J, et al
    Using evolutionary constraint to define novel candidate driver genes in medulloblastoma.
    Proc Natl Acad Sci U S A. 2023;120:e2300984120.
    PubMed     Abstract available
    
    
    
29. VOUTYRAKI C, Choromidis A, Meligkounaki A, Vlachopoulos NA, et al
    Growth deregulation and interaction with host hemocytes contribute to tumor progression in a Drosophila brain tumor model.
    Proc Natl Acad Sci U S A. 2023;120:e2221601120.
    PubMed     Abstract available
    
    
    
30. ZENG K, Zeng Y, Zhan H, Zhan Z, et al
    SEC61G assists EGFR-amplified glioblastoma to evade immune elimination.
    Proc Natl Acad Sci U S A. 2023;120:e2303400120.
    PubMed     Abstract available
    
    
    May 2023
31. RAVIRAM R, Raman A, Preissl S, Ning J, et al
    Integrated analysis of single-cell chromatin state and transcriptome identified common vulnerability despite glioblastoma heterogeneity.
    Proc Natl Acad Sci U S A. 2023;120:e2210991120.
    PubMed     Abstract available
    
    
    
32. WANG F, Huang Q, Su H, Sun M, et al
    Self-assembling paclitaxel-mediated stimulation of tumor-associated macrophages for postoperative treatment of glioblastoma.
    Proc Natl Acad Sci U S A. 2023;120:e2204621120.
    PubMed     Abstract available
    
    
    
33. MOTA M, Sweha SR, Pun M, Natarajan SK, et al
    Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas.
    Proc Natl Acad Sci U S A. 2023;120:e2221175120.
    PubMed     Abstract available
    
    
    April 2023
34. MISHRA-GORUR K, Barak T, Kaulen LD, Henegariu O, et al
    Pleiotropic role of TRAF7 in skull-base meningiomas and congenital heart disease.
    Proc Natl Acad Sci U S A. 2023;120:e2214997120.
    PubMed     Abstract available
    
    
    
35. CHIPMAN ME, Wang Z, Sun D, Pedraza AM, et al
    Tumor progression is independent of tumor-associated macrophages in cell lineage-based mouse models of glioblastoma.
    Proc Natl Acad Sci U S A. 2023;120:e2222084120.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.